An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
Abstract
Share and Cite
Susa, F.; Arpicco, S.; Pirri, C.F.; Limongi, T. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery. Pharmaceutics 2024, 16, 849. https://doi.org/10.3390/pharmaceutics16070849
Susa F, Arpicco S, Pirri CF, Limongi T. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery. Pharmaceutics. 2024; 16(7):849. https://doi.org/10.3390/pharmaceutics16070849
Chicago/Turabian StyleSusa, Francesca, Silvia Arpicco, Candido Fabrizio Pirri, and Tania Limongi. 2024. "An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery" Pharmaceutics 16, no. 7: 849. https://doi.org/10.3390/pharmaceutics16070849